158 related articles for article (PubMed ID: 34011343)
21. Evaluation of neurofibromatosis type 1 progression using a nationwide registry of patients who submitted claims for medical expense subsidies in Japan between 2008 and 2012.
Yamauchi T; Suka M; Nishigori C; Yanagisawa H
Orphanet J Rare Dis; 2019 Jul; 14(1):166. PubMed ID: 31277677
[TBL] [Abstract][Full Text] [Related]
22. Malignant peripheral nerve sheath tumours in neurofibromatosis 1.
Evans DG; Baser ME; McGaughran J; Sharif S; Howard E; Moran A
J Med Genet; 2002 May; 39(5):311-4. PubMed ID: 12011145
[TBL] [Abstract][Full Text] [Related]
23. A prospective study of neurofibromatosis type 1 cancer incidence in the UK.
Walker L; Thompson D; Easton D; Ponder B; Ponder M; Frayling I; Baralle D
Br J Cancer; 2006 Jul; 95(2):233-8. PubMed ID: 16786042
[TBL] [Abstract][Full Text] [Related]
24. Clinical and molecular characterization of neurofibromatosis in southern Brazil.
Rosset C; Vairo F; Cristina Bandeira I; Fonini M; Netto CBO; Ashton-Prolla P
Expert Rev Mol Diagn; 2018 Jun; 18(6):577-586. PubMed ID: 29685074
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment.
Lammert M; Friedman JM; Kluwe L; Mautner VF
Arch Dermatol; 2005 Jan; 141(1):71-4. PubMed ID: 15655144
[TBL] [Abstract][Full Text] [Related]
26. Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative.
Liu Q; Zoellner N; Gutmann DH; Johnson KJ
Fam Cancer; 2015 Jun; 14(2):317-24. PubMed ID: 25523354
[TBL] [Abstract][Full Text] [Related]
27. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
[TBL] [Abstract][Full Text] [Related]
28. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.
Balgobind BV; Van Vlierberghe P; van den Ouweland AM; Beverloo HB; Terlouw-Kromosoeto JN; van Wering ER; Reinhardt D; Horstmann M; Kaspers GJ; Pieters R; Zwaan CM; Van den Heuvel-Eibrink MM; Meijerink JP
Blood; 2008 Apr; 111(8):4322-8. PubMed ID: 18172006
[TBL] [Abstract][Full Text] [Related]
29. Coincidental Expression of Classic Hodgkin Lymphoma and Neurofibromatosis Type I and Literature Review.
Cabrera TB; Wang W; Yedururi S; Slopis JM; Steiner RE; Rytting ME; Cuglievan B
J Pediatr Hematol Oncol; 2021 May; 43(4):e535-e538. PubMed ID: 32366782
[TBL] [Abstract][Full Text] [Related]
30. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
31. Cancer incidence in France over the 1980-2012 period: Hematological malignancies.
Le Guyader-Peyrou S; Belot A; Maynadié M; Binder-Foucard F; Remontet L; Troussard X; Bossard N; Monnereau A;
Rev Epidemiol Sante Publique; 2016 Apr; 64(2):103-12. PubMed ID: 26973179
[TBL] [Abstract][Full Text] [Related]
32. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
Santoro C; Bernardo P; Coppola A; Pugliese U; Cirillo M; Giugliano T; Piluso G; Cinalli G; Striano S; Bravaccio C; Perrotta S
Ital J Pediatr; 2018 Mar; 44(1):41. PubMed ID: 29566708
[TBL] [Abstract][Full Text] [Related]
33. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
[TBL] [Abstract][Full Text] [Related]
35. The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features.
Ruggieri M; Polizzi A; Spalice A; Salpietro V; Caltabiano R; D'Orazi V; Pavone P; Pirrone C; Magro G; Platania N; Cavallaro S; Muglia M; Nicita F
Clin Genet; 2015 May; 87(5):401-10. PubMed ID: 25211147
[TBL] [Abstract][Full Text] [Related]
36. Spinal neurofibromatosis in a family with classical neurofibromatosis type 1 and a novel NF1 gene mutation.
Nicita F; Torrente I; Spalice A; Bottillo I; Papetti L; Pinna V; Ursitti F; Ruggieri M
J Clin Neurosci; 2014 Feb; 21(2):328-30. PubMed ID: 23954459
[TBL] [Abstract][Full Text] [Related]
37. Segmental neurofibromatosis type 1 complicated with multiple intracranial arteriovenous fistulas: A case study.
He D; Li Y; Yu Y; Cai G; Ouyang F; Lin Y; Lu H; Chu L
Clin Neurol Neurosurg; 2018 May; 168():108-111. PubMed ID: 29544172
[TBL] [Abstract][Full Text] [Related]
38. Increased risk for dementia in neurofibromatosis type 1.
Kallionpää RA; Valtanen M; Auranen K; Uusitalo E; Rinne JO; Peltonen S; Peltonen J
Genet Med; 2021 Nov; 23(11):2219-2222. PubMed ID: 34257422
[TBL] [Abstract][Full Text] [Related]
39. Endocrine morbidity in neurofibromatosis 1: a nationwide, register-based cohort study.
Kenborg L; Ebbehoj A; Ejerskov C; Handrup MM; Østergaard JR; Hove H; Doser K; Krøyer A; Mulvihill JJ; Winther JF; Stochholm K
Eur J Endocrinol; 2023 Aug; 189(2):190-198. PubMed ID: 37542520
[TBL] [Abstract][Full Text] [Related]
40. The pregnancy in neurofibromatosis 1: A retrospective register-based total population study.
Leppävirta J; Kallionpää RA; Uusitalo E; Vahlberg T; Pöyhönen M; Timonen S; Peltonen J; Peltonen S
Am J Med Genet A; 2017 Oct; 173(10):2641-2648. PubMed ID: 28815922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
